Finance

Lists
SKNY:CNSX
LIR Life Sciences Corp
CAD 0,20
0,00%
(0,00) 1D
13 Okt., 12:45:20 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SKNY...
Mkt. cap
5,73 m
Avg. vol.
17,86 k
Volume
0,00
52-wk high
CAD 2,41
52-wk low
CAD 0,10
EPS
-CAD 0,18
Mkt. cap
5,73 m
Avg. vol.
17,86 k
Volume
0,00
52-wk high
CAD 2,41
52-wk low
CAD 0,10
EPS
-CAD 0,18
News stories
From web sources and news partners
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersVancouver, Brits-Columbië, Kanada
SectorPharmaceutical industry
Websiteblackbirdmetals.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
6,67 k
5,00 k
Cost of revenue
-
-
6,67 k
5,00 k
Research and development expenses
-
10,00 k
52,10 k
255,17 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,85 k
1,13 m
317,32 k
323,37 k
Operating expense
67,88 k
1,87 m
1,23 m
981,44 k
Total operating expenses
67,88 k
1,87 m
1,24 m
986,44 k
Operating income
-67,88 k
-1,87 m
-1,24 m
-986,44 k
Other non operating income
-6,52 k
-343,44 k
-57,71 k
-3,70 k
EBT including unusual items
-64,24 k
-2,16 m
-1,40 m
-989,04 k
EBT excluding unusual items
-196,00 k
-2,21 m
-1,30 m
-989,04 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64,24 k
-2,16 m
-1,40 m
-989,04 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
142,00
-
-
20,00
Interest expense
-
-
-
-
Net interest expenses
10,69 k
-
-
20,00
Depreciation and amortization charges
-
-
1,28 k
-
EBITDA
-64,40 k
-1,87 m
-1,24 m
-985,20 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme